Systemic lupus erythematosus

2,463,808views

Systemic lupus erythematosus

Foundations

Foundations

Introduction to the immune system
Innate immune system
Complement system
Contracting the immune response and peripheral tolerance
Cytokines
Monoclonal antibodies
Antibody classes
Bacterial structure and functions
B-cell development
B-cell activation, differentiation, and contraction
T-cell development
T-cell activation
B- and T-cell memory
MHC class I and MHC class II molecules
Thymus histology
Cell cycle
Mitosis and meiosis
DNA replication
DNA damage and repair
DNA mutations
Cell membrane
Free radicals and cellular injury
Hypoxia
Necrosis and apoptosis
Inflammation
Crohn disease
Gout
Gout and pseudogout: Pathology review
Inclusion body myopathy
Inflammatory bowel disease: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Myasthenia gravis
Systemic lupus erythematosus
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Serum sickness
Anaphylaxis
Graft-versus-host disease
Systemic lupus erythematosus (SLE): Pathology review
Pemphigus vulgaris
Stevens-Johnson syndrome
Rheumatic heart disease
Heart failure: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Body fluid compartments
Movement of water between body compartments
Hyponatremia
Pulmonary edema
Lymphedema
Coagulation (secondary hemostasis)
Platelet plug formation (primary hemostasis)
Erythropoietin
Hemophilia
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Blood components
Protein C deficiency
Protein S deficiency
Metaplasia and dysplasia
Multiple endocrine neoplasia: Pathology review
Oncogenes and tumor suppressor genes
Amyloidosis
Atrophy, aplasia, and hypoplasia
Environmental and chemical toxicities: Pathology review
Medication overdoses and toxicities: Pathology review
Multiple endocrine neoplasia
Substance misuse and addiction: Clinical
Toxidromes: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Heparin-induced thrombocytopenia
Myocardial infarction
Shock
Arterial disease
Atherosclerosis and arteriosclerosis: Pathology review
Carbohydrates and sugars
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Fat-soluble vitamin deficiency and toxicity: Pathology review
Folate (Vitamin B9) deficiency
Iron deficiency anemia
Osteomalacia and rickets
Vitamin B12 deficiency
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Wernicke-Korsakoff syndrome
Zinc deficiency and protein-energy malnutrition: Pathology review
Burns: Clinical
Burns
Hyperplasia and hypertrophy
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Klinefelter syndrome
Turner syndrome
Angelman syndrome
Prader-Willi syndrome
Fragile X syndrome
DiGeorge syndrome
Phenylketonuria (NORD)
Homocystinuria
Maple syrup urine disease
Disorders of fatty acid metabolism: Pathology review
Ornithine transcarbamylase deficiency
Post-transplant lymphoproliferative disorders (NORD)
Cytomegalovirus infection after transplant (NORD)
Epigenetics
Gene regulation
Independent assortment of genes and linkage
Inheritance patterns
Mendelian genetics and punnett squares
Evolution and natural selection
Antiphospholipid syndrome
Celiac disease
Graves disease
Multiple sclerosis
Diabetes mellitus
Chronic granulomatous disease
Immunodeficiencies: Clinical
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Candida
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Pneumonia: Pathology review
Pneumonia
Salmonella (non-typhoidal)
Viral structure and functions
Hepatitis medications
Herpesvirus medications
Neuraminidase inhibitors
HIV (AIDS)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Integrase and entry inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Protease inhibitors
Vaccinations: Clinical
The flu vaccine: Information for patients and families
Vaccinations

Flashcards

Systemic lupus erythematosus

0 of 16 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 10 complete

Start
A 29-year-old woman comes to the office with joint pain and fatigue. For the past three months, she has felt excessive fatigue with normal activity, associated with poor appetite, and a 5 lb (2.3 kg) weight loss. The joint pains are characterized by stiffness in her fingers and wrists that lasts an hour after waking up, and usually improve throughout the day. The patient’s temperature is 38.0°C (100.4°F), pulse is 77/min, respirations are 18/min, and blood pressure is 115/76 mmHg. She appears tired. Physical examination shows symmetrically swollen and tender wrists bilaterally, and abdominal examination shows splenomegaly. Examination of the patient’s face is shown below:  


 Reproduced from: Wikimedia commons    

Follow-up laboratory studies show the following:  

Laboratory value  Result Reference Range 
Hemoglobin  9.0 g/dL  12-16 g/dL 
 Leukocyte count  3,800/mm3  4,500-11,000/mm3 
 Platelet count  125,000/mm3  150,000-400,000/mm3 

Which of the following is the most likely cause of this patient’s laboratory findings?  

Transcript

Watch video only

Content Reviewers

Alright, “systemic lupus erythematosus,” k we totally got this. “Systemic” is easy, and refers to affecting multiple organs in the body.

“Erythematosus” means reddening of the skin, alright alright.

Lupus” is latin for “wolf”. So affects multiple organs wolf...reddening of the skin?

Not exactly, the modern use of lupus usually refers to a variety of diseases that affect the skin...which was possibly originally used since these diseases resemble a wolf bite on the patients’ skin.

Is that true? Who knows. At any rate, systemic lupus erythematosus, or SLE, sometimes just lupus, is a disease that’s systemic, and affects a wide variety of organs, but notably often causes red lesions on the skin.

But how does lupus affect all these organs? Well usually the immune system protects the body’s tissues from invaders, but lupus is an autoimmune disease, which means that immune cells start attacking the very tissues their supposed to protect.

With lupus, essentially any tissue or organ can be targeted.

And just like a ton of other autoimmune diseases though, it’s not completely clear why it develops, and like most diseases it’s the result of both genetics and the environment.

Alright so let’s go over a specific scenario to show how this plays out.

Let’s say this guy has susceptibility genes—genes that make him susceptible to getting lupus, and he’s exposed to UV radiation in sunlight, which we know is an environmental risk factor for lupus.

Well, given enough UV rays, think like sunburn, the cell’s DNA can become so badly damaged, that the cell undergoes programmed cell death, or apoptosis, and it dies.

This produces all these little apoptotic bodies, and exposes the insides of the cell, including parts of the nucleus, like DNA, histones, and other proteins, to the rest of the body.

Well those susceptibility genes specifically have an effect on this person’s immune system such that their immune cells are more likely to think that these are foreign, or antigens, and since they’re from the nucleus, we call them nuclear antigens, and immune cells try to attack them.

Not only that though, susceptibility genes also cause this person to have less effective clearance, essentially they aren’t as good at getting rid of the apoptotic bodies and so they end up having more nuclear antigens floating around.

This means that B cells might swing by, see them, and start the production of antibodies against these pieces of nucleus, which are called antinuclear antibodies, and these guys are present in almost all cases of lupus.

Alright so those antinuclear antibodies bind to the nuclear antigens, forming antigen-antibody complexes.

These complexes can get into the blood and then drift away and deposit or stick to the vessel wall in all sorts of different organs and tissues like the kidneys, skin, joints, heart.

Deposited complexes then initiate a local inflammatory reaction, which causes damage through the activation of the complement system, which, after a huge cascade of enzyme activation, leaves cell membranes with channels that let fluid and molecules go in and out all willy nilly, causing the cell to burst and die, usually though you’d want this to happen to foreign cell or an infected cell, not healthy cells.

When tissues become damaged as a result of these immune complexes, it’s known as a type III hypersensitivity reaction.

UV radiation isn’t the only way to damage cells, though, right?

It therefore isn’t the only trigger that’s thought to be associated with lupus—other potential triggers that have been associated with SLE include cigarette smoking, viruses, bacteria, use of certain medications like procainamide, hydralazine, and isoniazid, as well as sex hormones, particularly estrogen, which might be partly why lupus is more common in women, especially considering it’s about 10 times more common in women than men during reproductive years, but only about 2 or 3 times more common in childhood or past the age of 65.

Okay okay, as a quick recap, the model that’s generally thought to be what leads to SLE starts with some environmental trigger, which damages cells, and causes apoptosis and the release of nuclear antigens.

At this point, the genetic components come in, and the person likely has certain genes that make them not so good at clearing these apoptotic bodies and nuclear antigens, so you end up with a lot of nuclear antigens floating around.

In combination, they probably also have genes that cause their immune cells to recognize these nuclear antigens as foreign, which initiates an immune response, creates antinuclear antibodies that bind to antigens and then float around and deposit in various tissues, which causes inflammation.

These deposits and inflammation seem to be the cause of most of the symptoms of lupus, which remember is a type III hypersensitivity reaction.

Many patients, though, also develop antibodies targeting other cells like red and white blood cells, and molecules like various phospholipids, which can mark them for phagocytosis and destruction, leading to additional symptoms.

Key Takeaways

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease in which the body's immune system mistakenly attacks healthy tissue. SLE most often harms the heart, joints, skin, lungs, blood vessels, liver, kidneys, and nervous system. Common symptoms of SLE can include fatigue, joint pain, rash, fever, and anemia. The course of the disease is unpredictable, with periods of illness (called flare-ups) alternating with remissions. Treatment typically involves medications to manage symptoms, reduce inflammation, and suppress the immune system.